LEBEL FRANCOIS (Chief Medical Officer) received a stock award from SPECTRUM PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/24/2021ACC: 0001209191-21-013884
Officer· Chief Medical Officer
Since Jun 2019
+558.23K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
558.23K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Direct
Shares
+110.31K
Price / share
—
Trade value
—
% of position
35.8%
2/18/2021
308.22K→418.53K
Total
Net shares
+110.31K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 2/18/2021 | A · Award | +110.31K | — | — | 35.8% | 308.22K | 418.53K |
| Total | +110.31K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
133.71K shares
Shares
+133.71K
Strike price
3.56
Held after
133.71K
Exercisable
—
2/18/2021
Stock Appreciation Right
Direct
Converts to
Common Stock
314.21K shares
Shares
+314.21K
Strike price
3.56
Held after
314.21K
Exercisable
—
2/18/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock133.71K shares | 2/18/2021 | A · Award | +133.71K | 3.56 | — | 133.71K |
| Stock Appreciation Right Direct | Common Stock314.21K shares | 2/18/2021 | A · Award | +314.21K | 3.56 | — | 314.21K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.001 par value
IndirectShares owned7.23K
Total
7.23K indirect7.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 7.23K | Indirect |
| Total | 7.23K | 7.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported